Log In
Print
BCIQ
Print
Print this Print this
 

Aristada, aripiprazole lauroxil (ALKS 9070)

Also known as: ALKS 9072

  Manage Alerts
Collapse Summary General Information
Company Alkermes plc
DescriptionInjectable, extended-release formulation of aripiprazole using LinkeRx technology
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT) receptor
Mechanism of ActionDopamine D2 receptor agonist; Serotonin (5-HT1A) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today